#60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

1

Introduction

00:00 • 2min

2

COVID-19: A Late Breakers Session

02:27 • 6min

3

The Impressed You Trial

08:08 • 5min

4

Deloro Back-Damned: A Novel Beta Lactamase Inhibitor

13:08 • 2min

5

Asinidobacter: A Drug That Might Actually Be Effective

15:34 • 4min

6

The Cost-Effectiveness of Beta Lactamase Inhibitors

19:50 • 2min

7

Meta-Cyclone and Outpatient Use

22:07 • 2min

8

The Effects of Stewardship on Antibiotic Use

23:43 • 3min

9

The Importance of Stewardship in Antibiotic Use

27:00 • 5min

10

Beta Lactams and Severe Sepsis

31:30 • 2min

11

The Role of Beta Lactams in Treatment of Sepsis

33:53 • 4min

12

The Role of Beta Lactam in the Treatment of Bloodstream Infections

37:26 • 2min

13

The Importance of Having Accurate and Timely Diagnostics

38:56 • 4min

14

The Role of Teso Back-Tam in Esbl Treatment

43:18 • 4min

15

The Importance of Stenotrophomonas

47:07 • 3min

16

Steno: Random Things That Happened That Are Extremely Cool

50:21 • 3min

17

Antibiotic Inertia and Stewardship

53:51 • 4min

18

The Pharmacist Driven Transitions of Care Model for Antibiotic Prescription at Discharge

58:01 • 3min

19

The Impact of Pharmacists on Telus Stewardship

01:01:17 • 3min

20

MRSA Surveillance Cultures and Pneumonia

01:04:25 • 4min

21

The Anti Fungal Pipeline in Drugs

01:07:57 • 4min

22

The Flagstone Study of Bollocks Severe Flu

01:11:31 • 4min

23

Antiflankens and a New Antiviral

01:15:06 • 4min

24

The Effects of Morebivir on CMV Clearance

01:18:38 • 3min

25

The Future of Antibiotics

01:21:16 • 2min

26

Bayesian Dosing for COVID

01:23:43 • 4min

27

The New Guidelines for Dental Procedures

01:27:58 • 3min